First Patient Enrolled and Randomized in Global #ClinicalTrial Evaluating Ablative Solution’s Novel Therapy for Uncontrolled #Hypertension -
TARGET BP Clinical Program studies #renaldenervation using the investigational Peregrine System Kit https://t.co/Zvxg9zyCVu
Prof. Horst Sievert presented Peregrine Post-Market study results for the CE-marked Peregrine Catheter at #CRT2019 on behalf of European investigators. https://t.co/XoxH0RBGtY
Congrats to Ablative Solutions on $77 million raise to support its global clinical program for new #renaldenervation#hypertension treatment https://t.co/TCT5HFOeoI